First person – Jenny Vermeer and Jonathan lent
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the...
Format: | Article |
---|---|
Language: | English |
Published: |
The Company of Biologists
2020-07-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/13/7/dmm046292 |
id |
doaj-4c0d9af64b5a49ba9c7869aca92716a8 |
---|---|
record_format |
Article |
spelling |
doaj-4c0d9af64b5a49ba9c7869aca92716a82020-11-25T03:07:59ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112020-07-0113710.1242/dmm.046292046292First person – Jenny Vermeer and Jonathan lentFirst Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the fate of hypoxic tumour cells’, published in DMM. Jenny conducted the research described in this article while a postdoctoral researcher in the lab of Ruth Muschel at the University of Oxford, Oxford, UK. She is now a project leader in the lab of Miranda van der Lee at Byondis, Nijmegen, The Netherlands, investigating new targets, particularly in cancer, that will lead to novel treatments. Jonathan is a PhD student in the lab of Marc Vooijs at Maastricht University, Maastricht, The Netherlands, investigating new cancer targets and testing possible new interventions with a focus on tumour hypoxia.http://dmm.biologists.org/content/13/7/dmm046292 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
title |
First person – Jenny Vermeer and Jonathan lent |
spellingShingle |
First person – Jenny Vermeer and Jonathan lent Disease Models & Mechanisms |
title_short |
First person – Jenny Vermeer and Jonathan lent |
title_full |
First person – Jenny Vermeer and Jonathan lent |
title_fullStr |
First person – Jenny Vermeer and Jonathan lent |
title_full_unstemmed |
First person – Jenny Vermeer and Jonathan lent |
title_sort |
first person – jenny vermeer and jonathan lent |
publisher |
The Company of Biologists |
series |
Disease Models & Mechanisms |
issn |
1754-8403 1754-8411 |
publishDate |
2020-07-01 |
description |
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the fate of hypoxic tumour cells’, published in DMM. Jenny conducted the research described in this article while a postdoctoral researcher in the lab of Ruth Muschel at the University of Oxford, Oxford, UK. She is now a project leader in the lab of Miranda van der Lee at Byondis, Nijmegen, The Netherlands, investigating new targets, particularly in cancer, that will lead to novel treatments. Jonathan is a PhD student in the lab of Marc Vooijs at Maastricht University, Maastricht, The Netherlands, investigating new cancer targets and testing possible new interventions with a focus on tumour hypoxia. |
url |
http://dmm.biologists.org/content/13/7/dmm046292 |
_version_ |
1724667892248608768 |